MGTXNasdaq

MeiraGTx Holdings plc

Healthcare·Neurology·Phase 1·New York, NY, United States
NeurologyOphthalmologyMetabolic

MeiraGTx Holdings plc (MGTX): 5 pipeline candidates · ~6 mo cash runway. Updated within the last hour.

5.3/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway1.6

5.9 months

Financial Health10.0

D/E -5.21 · 0% dilution

Pipeline Maturity4.0

Lead: Phase 1

Pipeline Breadth8.5

5 candidates

Catalyst MomentumN/A

N/A

Insider Signal2.2

0 buys · 4 sells (180d)

A transparent, data-derived signal for MeiraGTx Holdings plcacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$898.3M

Cash

$73.8M

Quarterly Burn

$41.1M

Runway

5.9 mo

Revenue

$293K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Dec 2026
Today~7 mo out
Catalyst within runway

Pipeline (5 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

130

Total value held

$489.8M

HolderSharesValue
perceptive advisors llc20,652,206$178.6M
johnson & johnson6,641,064$57.5M
adage capital partners gp, l.l.c.4,000,000$34.6M
millennium management llc3,465,699$30.0M
blackrock, inc.3,168,148$27.4M
prosight management, lp2,629,971$22.8M
683 capital management, llc2,450,000$21.2M
morgan stanley1,589,940$13.8M
knoll capital management, llc1,250,000$10.8M
kennedy capital management llc858,379$7.4M

Showing top 10 of 130 institutional holders of MeiraGTx Holdings plc. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Dr. Alexandria Forbes Ph.D.

Frequently asked questions

How many drug candidates are in MeiraGTx Holdings plc's pipeline?

MeiraGTx Holdings plc (MGTX) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is MeiraGTx Holdings plc's lead drug candidate?

MeiraGTx Holdings plc's most advanced tracked candidate is aav-aipl1 (Preclinical) for Leber congenital amaurosis 4 (LCA4).

What is MeiraGTx Holdings plc's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, MeiraGTx Holdings plc has approximately 5.9 months of cash runway.

What is MeiraGTx Holdings plc's market capitalization?

MeiraGTx Holdings plc's market capitalization is approximately $898.3M.

Who is the CEO of MeiraGTx Holdings plc?

Dr. Alexandria Forbes Ph.D. is the chief executive officer of MeiraGTx Holdings plc (MGTX).

Get the full picture on MeiraGTx Holdings plc

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.